AmerisourceBergen Corporation with ticker code (ABC) have now 12 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 180 and 139 and has a mean target at 153.92. With the stocks previous close at 152 this is indicating there is a potential upside of 1.3%. There is a 50 day moving average of 139.87 and the 200 day MA is 125.88. The company has a market cap of $32,260m. Visit the company website at: https://www.amerisourcebergen.com
The potential market cap would be $32,668m based on the market concensus.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, luding acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, luding hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company’s Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was orporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
